Alimohammadvand Sajjad, Zenjanab Masoumeh Kaveh, Pakchin Parvin Samadi, Abdolahinia Elaheh Dalir, Barar Jaleh, Omidi Yadollah, Pourseif Mohammad M, Fathi Marziyeh, Shayegh Jalal
Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Basic Sciences, Faculty of Veterinary Medicine, Shabestar Branch, Islamic Azad University, Shabestar, Iran.
BMC Biotechnol. 2024 Dec 24;24(1):108. doi: 10.1186/s12896-024-00939-1.
Breast cancer, a formidable global health challenge for women, necessitates innovative therapeutic strategies with enhanced efficacy and minimal side effects. Aripiprazole (ARI), a widely used schizophrenia medication, exhibits promising potential in the treatment of breast cancer. As cancer therapy evolves towards a combination approach, multimodal nano-based delivery systems, such as ARI-loaded niosomes (NIOs) combined with Chitosan-Au nanoparticles for chemo-photothermal therapy, show promise over traditional chemotherapy alone by enhancing targeted efficacy and minimizing side effects.
In this study, a niosomal formulation was designed, incorporating ARI and chitosan-coated AuNPs (i.e. NIOs/AuNPs-CS/ARI), to study the synergistic effect of photothermal/chemotherapy in breast cancer cells.
The nanosystems were characterized using UV-Vis spectroscopy and Fourier-transform infrared spectroscopy (FT-IR), confirming the successful synthesis steps. The hydrodynamic diameter of NIOs/AuNPs-CS was determined to be 44.62 nm with a zeta potential of -0.836. Also, Transmission Electron Microscopy (TEM) and Field-Emission Scanning Electron Microscopical (FE-SEM) analysis were performed to assess the size and morphology of NPs. The loading efficiency of ARI in NIOs and NIOs/AuNPs-CS was 75% and 88%, respectively. Furthermore, the release rate of the drug from NIOs/AuNPs-CS is higher than blank NIOs at two pH values (5.8 and 7.4). The cellular uptake of AuNPs-CS-encapsulated NIOs was considerably higher than that of blank NIOs. The Annexin V/PI staining assay showed that the apoptosis/necrosis rate was high in NIOs/AuNPs-CS/ARI (46%) and NIOs/ARI (36%) in 48 h. The results of MTT assessments demonstrated higher cytotoxicity by ARI-loaded NPs. The viability of MCF-7 cells treated with NIOs/AuNPs-CS/ARI was reduced from 60% and 50% to 40% and 20%, respectively, after 24 and 48 h upon laser irradiation.
The results of this experiment demonstrated the remarkable effectiveness of NIOs/AuNPs-CS/ARI in cancer treatment, owing to their unique properties, including the PTT capability and pH sensitivity.
乳腺癌是全球女性面临的一项严峻的健康挑战,需要创新的治疗策略,以提高疗效并减少副作用。阿立哌唑(ARI)是一种广泛使用的精神分裂症药物,在乳腺癌治疗中显示出有前景的潜力。随着癌症治疗向联合治疗方法发展,基于纳米的多模态递送系统,如负载ARI的脂质体(NIOs)与壳聚糖-金纳米颗粒联合用于化学-光热疗法,通过提高靶向疗效和最小化副作用,比单独的传统化疗更具前景。
在本研究中,设计了一种脂质体制剂,将ARI和壳聚糖包被的金纳米颗粒(即NIOs/AuNPs-CS/ARI)结合,以研究光热/化疗在乳腺癌细胞中的协同作用。
使用紫外-可见光谱和傅里叶变换红外光谱(FT-IR)对纳米系统进行了表征,证实了成功的合成步骤。NIOs/AuNPs-CS的流体动力学直径测定为44.62 nm,zeta电位为-0.836。此外,进行了透射电子显微镜(TEM)和场发射扫描电子显微镜(FE-SEM)分析,以评估纳米颗粒的大小和形态。ARI在NIOs和NIOs/AuNPs-CS中的负载效率分别为75%和88%。此外,在两个pH值(5.8和7.4)下,药物从NIOs/AuNPs-CS中的释放速率高于空白NIOs。壳聚糖包被金纳米颗粒的NIOs的细胞摄取量明显高于空白NIOs。Annexin V/PI染色分析表明,在48小时内,NIOs/AuNPs-CS/ARI(46%)和NIOs/ARI(36%)中的凋亡/坏死率较高。MTT评估结果表明,负载ARI的纳米颗粒具有更高的细胞毒性。经激光照射24和48小时后,用NIOs/AuNPs-CS/ARI处理的MCF-7细胞的活力分别从60%和50%降至40%和20%。
本实验结果表明,NIOs/AuNPs-CS/ARI因其独特的性质,包括光热疗法能力和pH敏感性,在癌症治疗中具有显著效果。